Josh Cheema, MD, MSCI, MSAI

❤️ Advanced HF & Tx @NMCardioVasc l HCM Doc | Using AI/ML advance patient care

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

Out now in @JACCJournals, see our State-Of-The-Art review summarizing the latest evidence for and against IV iron in HF! 💉❤️ #HeartFailure #MedTwitter #IronTherapy @ArdehaliHossein

https://t.co/ZRz8KRTqgY

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

@David_Ouyang Has totally rejuvenated my desire to get more dangerous writing code myself. I am fully addicted to building things with Claude Code!

[NM Cardiovascular @NMCardioVasc]

"Too much detail without guidance risks overwhelming people with information that isn’t clinically actionable." Baljash S. Cheema, MD (@JCheemaMD), provides thought leadership on both the benefits and potential risks associated with the DEXA scan and which patients this may help. https://t.co/n7TCIqMSHh

[Journal of Cardiac Failure @JCardFail]

🖥️AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias warrant further study.

Read the latest Review: https://t.co/gArn5t02tJ

[Cathy Gao-Howard, MD MS @CatGaoHow]

So honored and grateful for this! Thanks to all the mentors and team members who have supported me. 💖 Looking forward to exciting new work together with @IAIM_NU @IPHAM_CHIP @NM_Lung @NUFeinbergMed and many others!

[NM Cardiovascular @NMCardioVasc]

In this article, medical experts including Baljash Cheema, MD (@JCheemaMD), discuss how #ArtificialIntelligence can affect decisions in #PatientCare, using a real-life case of a patient with advanced #HeartFailure as an example. They highlight the strengths and challenges of the current state of #AI in medicine by exploring a handful of representative technologies. https://t.co/PXedI7gxQ9

[NU Internal Medicine @NU_IntMed]

Please help us #congratulate @AkhilNarangMD for being promoted to Associate Professor of Medicine in the division of Cardiology @NMCardioVasc !

#congratulations #departmentofmedicine #nmim

[Nilay Shah @NilayShahMDMPH]

Do US Asians get equitable MI quality of care?

In @AHAScience GWTG of >700 US hospitals,

Door-to-balloon time <90 mins less likely in Indian men, Filipina women vs. White

OMT for MI less likely in Korean men vs White

@CircOutcomes: https://t.co/snAij7CUE4

[Quentin Youmans, MD, MSc @QuentinYoumans]

Enjoyed a great day in the #cathlab this week with our new fellows tackling some complex cases!

One thing’s for sure, @NMCardioVasc is a great place to train for #AdvHFTx Cardiology training with the perfect mix of pt complexity, teaching and autonomy all in the 💜 of #Chicago!

[Sarah Chuzi, MD, MSc @SarahChuzi]

⭐️Our piece (w/ Sarah Godfrey & Katie Manning) on How to be a Palliative Cardiologist is out in @JCardFail ⭐️

Here, we describe unique training pathways & career phenotypes for HF 🧑🏾‍⚕️ who want to cultivate a niche in pall care.

📣Trainees- it’s possible & extremely rewarding!

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

Not enough time to read our review on IV iron in HF? See this expert summary of the paper, narrated by the one and only Dr. Valentin Fuster. @JACCJournals
https://t.co/lL2mBK15Kt

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

@NorthwesternMed @NMCardioVasc @NMHheartdoc

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

Out now in @JACCJournals, see our State-Of-The-Art review summarizing the latest evidence for and against IV iron in HF! 💉❤️ #HeartFailure #MedTwitter #IronTherapy @ArdehaliHossein

https://t.co/ZRz8KRTqgY

[Hossein Ardehali @ArdehaliHossein]

Check out our latest review. Thanks to @JCheemaMD for his excellent work. @BioIronSocial @nu_fcvrri @NorthwesternMed @NMCardioVasc @NMHheartdoc
Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency: JACC State-of-the-Art Review https://t.co/rJ6htZF5wC

[Neal Chatterjee @Nchatterjeemd]

Delighted to share our work predicting cardiac arrest in the general population using machine learning and electronic health records. Grateful to @CircAHA for the platform. A years-long interdisciplinary team effort - more to come!

https://t.co/x4wKIbE61Y

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

Now out in JACC Advances, our viewpoint on AI within HF and how the future may look with the help of multimodality large language models @JayPandit

https://t.co/CzrsM2hSMU

[NM Cardiovascular @NMCardioVasc]

Join Northwestern Medicine scientists at ACC.24 for poster session, “Timeline Of The Development Of Cardiovascular Adverse Events Following Treatment With Chimeric Antigen Receptor T Cell Therapies.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BLs4

[NM Cardiovascular @NMCardioVasc]

At ACC.24, check out Akhil Narang, MD (@AkhilNarangMD) , for his session, “Planning For Your Procedure: The Value of Multimodality Imaging.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BLs4

[NM Cardiovascular @NMCardioVasc]

Join Robert O. Bonow, MD, at ACC.24 for his session, “Hungry Heart: How Can Clinical Guidance Keep Pace With the Speed of Valve Therapies?” @ACCinTouch #ACC24 #NMatACC See full schedule here: https://t.co/yaahN8BLs4

[NM Cardiovascular @NMCardioVasc]

At ACC.24, join Sarah E. Chuzi, MD (@SarahChuzi), for her panel session, “Futility Versus Blind Heroism: Where Do We Draw the Line in Cardiogenic Shock and Cardiac Arrest?” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BdCw

[NM Cardiovascular @NMCardioVasc]

At ACC.24, check out Paul C. Cremer, MD, for his panel session, “Multi-Modality Imaging in Patients With Recurrent Pericarditis.” @ACCinTouch #ACC24 #NMatACC. See the full schedule here: https://t.co/yaahN8BdCw